Hemophilia | Pfizer Información Médica

Materiales de Congresos

La información de esta página es seleccionada de materiales de congresos, áreas terapéuticas y de enfermedades. No pretende servir como una descripción general completa de todos los contenidos mencionados

Volver al áreas de Enfermedades

Presentación Oral

Debra Pittman Julio 9, 2022 ISTH 2022 Hemofilia

Effect of Growth on AAV-mediated Expression of FIX-R338L in Juvenile Hemophilia B Dogs

Ver Presentación

Póster

Patrick F Fogarty, Brinda K Tammara, Justin Smith, Delphine Agathon, Florence Ganne, Frank Plonski, Jeremy Rupon Agosto 16, 2022 THSNA 2022 Hemofilia

Clearance of Giroctocogene Fitelparvovec Vector DNA in Adults With Severe Hemophilia A

Ver Presentación

Póster

John Teeter, Robert Charnigo, Nandini Cossons, Sangeeta Raje, Eunhee Hwang, Thomas Le Duigou Agosto 25, 2022 NHF 2022 Hemofilia

Safety and Efficacy of Marstacimab for Prevention of Bleeding Episodes in Pediatric Patients With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B With or Without Inhibitors

Ver Presentación

Póster

Debra D Pittman, Charles Carrieri, Holly Soares, John McKay, Charles Tan, John Liang, Swapnil Rakhe, Jean-Claude Marshall, John Murphy, Jeremy Rupon Agosto 26, 2022 NHF 2022 Hemofilia

Preliminary Field Study Results Suggest Differences in FIX Activity Based on Assay From Gene Therapy Trial Patients Expressing R338L High-Activity Variant of FIX

Ver Presentación

Póster

Y. GU, K. HUANG, X. SUN, X. ZHOU, R. SHEN, L. Young, A. CHHABRA, G. DIRUSSO, J. RUPON and I. WINBURN Diciembre 10, 2022 ASH 2022 Hemofilia

A Retrospective Cohort Study of Switching Patterns among Hemophilia A and B Patients using Optum Electronic Health Records (EHR) Database in the United States (US)

Ver Presentación

Póster

John Rasko, George Bashirians, Christos J Petropoulos, Terri Wrin, Yuvika Paliwal, Peter V Henstock, Suryanarayan Somanathan, Michelle Casey, Candida da Fonseca Pereira, Ian Winburn, Amit Chhabra Diciembre 10, 2022 ASH 2022 Hemofilia

Global Seroprevalence of Neutralizing Antibodies Against Adeno-Associated Virus (AAV) Serotypes of Relevance to Gene Therapy

Ver Presentación

Póster

Adam Giermasz, Nathan Visweshwar, Thomas J Harrington, Andrew D Leavitt, Barbara A Konkle, Jeremy Rupon, Gregory Di Russo, Li-Jung Tseng, Maria de los Angeles Resa, Florence Ganne, Delphine Agathon, Frank Plonski, Didier Rouy, Bettina M Cockroft, Annie Fang, Steven Arkin Diciembre 10, 2022 ASH 2022 Hemofilia

Updated Results of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (PF-07055480/SB-525) Gene Therapy in Adults With Severe Hemophilia A

Ver Presentación

Presentación Oral

Kavakli K, Fuiman J, McKay J, Sun P, Rupon J Febrero 9, 2023 EAHAD 2023 Hemofilia

Efficacy and Safety of Fidanacogene Elaparvovec in Adults With Moderately Severe to Severe Hemophilia B: the Phase 3 BENEGENE-2 Gene Therapy Trial

Ver Presentación

Póster

Rasko J, Chhabra A, Ducore JM, George LA, Giermasz A, High KA, McGuinn CE, O’Brien A, Rupon J, Samelson-Jones BJ, Smith LM, Sullivan SK, Teitel JM, Winburn I Febrero 9, 2023 EAHAD 2023 Hemofilia

Patterns of Joint Bleeds in Patients With Hemophilia B Following Fidanacogene Elaparvovec Adeno-Associated Virus Gene Therapy

Ver Presentación

Póster

Rasko J, Bashirians G, Petropoulos CJ, Wrin T, Somanathan S, Paliwal Y, Henstock PV, da Fonseca Pereira C, Winburn I, Chhabra A Febrero 9, 2023 EAHAD 2023 Hemofilia

Seroprevalence of Neutralizing Antibodies Against Adeno-Associated Virus Serotypes of Relevance to Gene Therapy in Europeans

Ver Presentación